Abstract
There are various types of hepatic lesions, both benign and malignant. This section focuses on benign liver lesions, their diagnosis, and management.
The appropriate diagnosis of benign liver lesions depends on the clinical history, including a history of past liver disease, risk factors, certain laboratory measurements, and imaging characteristics, and on rare occasions, biopsy of the lesion. Management of most benign lesions includes observation, unless they are symptomatic, in which case referral for surgery may be necessary. Hepatic adenomas occasionally have malignant potential or carry a risk of growth during pregnancy or oral contraceptive use and may require discontinuation of these medications, or if growing or a high potential for malignancy, they may require surgery. A brief summary of the diagnosis and management of benign hepatic lesions can be found in.
The presence of underlying liver disease, particularly cirrhosis attributed to chronic viral hepatitis B or C or hemochromatosis, should alert the clinician to a higher likelihood of malignancy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg. 1995;19(1):19–24.
Gandolfi L et al. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut. 1991;32(6):677–80.
DuPre CT, Fincher RM. Case report: cavernous hemangioma of the liver. Am J Med Sci. 1992;303(4):241–4.
Saegusa T et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med. 1995;34(3):207–11.
Gemer O et al. Oral contraceptives and liver hemangioma: a case-control study. Acta Obstet Gynecol Scand. 2004;83(12):1199–201.
Kasabach H, Merritt K. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child. 1940;59:1063–70.
Lee MG et al. The diagnostic accuracy/efficacy of MRI in differentiating hepatic hemangiomas from metastatic colorectal/breast carcinoma: a multiple reader ROC analysis using a jackknife technique. J Comput Assist Tomogr. 1996;20(6):905–13.
McFarland EG et al. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology. 1994;193(1):43–7.
Ehrl D et al. “Incidentaloma” of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg. 2012;2012:891787.
Shaked O, et al. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol. 2012; 9(7): 547–62 e1–4.
Rooks JB et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242(7):644–8.
Carrasco D et al. Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature. J Hepatol. 1985;1(6):573–8.
Resnick MB, Kozakewich HP, Perez-Atayde AR. Hepatic adenoma in the pediatric age group. Clinicopathological observations and assessment of cell proliferative activity. Am J Surg Pathol. 1995;19(10):1181–90.
Bioulac-Sage P, et al. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int. 2012;32(8):1217–21.
Bunchorntavakul C, et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther. 2011;34(6):664–74.
Farges O, et al. Changing trends in malignant transformation of hepatocellular adenoma. Gut. 2011;60(1):85–9.
Cho SW et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15(10):2795–803.
Deneve JL et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol. 2009;16(3):640–8.
Ribeiro Junior MA et al. Surgical management of spontaneous ruptured hepatocellular adenoma. Clinics (Sao Paulo). 2009;64(8):775–9.
Grazioli L et al. Hepatic adenomas: imaging and pathologic findings. Radiographics. 2001;21(4):877–92. discussion 892–4.
Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg. 1988;208(5):558–64.
Broker ME et al. The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach. Int J Hepatol. 2012;2012:725735.
Parker P et al. Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. Gastroenterology. 1981;81(3):534–6.
Flejou JF et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology. 1985;89(5):1132–8.
Ribeiro A et al. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg. 1998;4(5):388–98.
Craig JR, et al. Tumor of the liver and intrahepatic bile ducts. Armed Forces Institute of Pathology, Washington DC: Atlas of Tumor Pathology: 1989. p. 280.
Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol. 1986;39(2):183–8.
Cherqui D et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology. 1995;22(6):1674–81.
Luciani A et al. Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut. 2002;50(6):877–80.
Cowles RA, Mulholland MW. Solitary hepatic cysts. J Am Coll Surg. 2000;191(3):311–21.
Doty JE, Tompkins RK. Management of cystic disease of the liver. Surg Clin North Am. 1989;69(2):285–95.
D’Agata ID et al. Combined cystic disease of the liver and kidney. Semin Liver Dis. 1994;14(3):215–28.
Summerfield JA et al. Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol. 1986;2(2):141–56.
Karhunen PJ, Tenhu M. Adult polycystic liver and kidney diseases are separate entities. Clin Genet. 1986;30(1):29–37.
Hansman MF et al. Management and long-term follow-up of hepatic cysts. Am J Surg. 2001;181(5):404–10.
Lee JH et al. Biliary cystadenoma and cystadenocarcinoma of the liver: 10 cases of a single center experience. Hepatogastroenterology. 2009;56(91–92):844–9.
Sanchez H et al. Surgical management of nonparasitic cystic liver disease. Am J Surg. 1991;161(1):113–8. discussion 118–9.
Vogt DP, Henderson JM, Chmielewski E. Cystadenoma and cystadenocarcinoma of the liver: a single center experience. J Am Coll Surg. 2005;200(5):727–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rizvi, S. (2017). Benign Liver Lesions. In: Saeian, K., Shaker, R. (eds) Liver Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-30103-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-30103-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30101-3
Online ISBN: 978-3-319-30103-7
eBook Packages: MedicineMedicine (R0)